Novartis Blood Cancer Drug Suits Centralized In Florida
The Judicial Panel on Multidistrict Litigation on Tuesday centralized 18 suits alleging that Novartis Pharmaceuticals Inc.'s blood cancer drug Tasigna causes cardiovascular disease, finding that more suits over the drug are...To view the full article, register now.
Already a subscriber? Click here to view full article